YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperlipidemia
Conditions
Hyperlipidemia, Hypertension
Trial Timeline
Nov 1, 2013 → Jun 1, 2014
NCT ID
NCT01914432About YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placebo
YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placebo is a phase 3 stage product being developed by Yuhan for Hyperlipidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01914432. Target conditions include Hyperlipidemia, Hypertension.
What happened to similar drugs?
6 of 20 similar drugs in Hyperlipidemia were approved
Approved (6) Terminated (1) Active (13)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01914432 | Phase 3 | Completed |
Competing Products
20 competing products in Hyperlipidemia